LEGN Legend Biotech
Legend Biotech earnings company data as of 4:48 AM ET 10/23
Scheduled
1 period, newest first, nothing reported yet. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 11 Nov | EPS | 0.02 | — | — |
| Rev | — | — | — |
Insider trades
Open-market buys and sales by LEGN's executives, directors and 10% owners in the last 12 months, from their Form 4s
- None no insider bought on the open market
- $348K sold by 2 insiders outside a trading plan
- None no planned (10b5-1) sales
-
Corazon (Corsee) D. Sanders DirectorSale$259K 27,370 shares at $9.46 34% of stakeTraded Sep 29 Filed Oct 1
-
Patrick John Casey DirectorSale$89K 6,000 shares at $14.80 11% of stakeTraded Jun 30 Filed Jul 2
Also filed in the last 12 months, not counted as buying or selling: 9 stock grants, 3 sales to cover taxes, and 1 gift.
SEC filings
Recent issuer filings from EDGAR, 25 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| 6-K | FORM 6-K | Filing Doc | |
| 6-K | FORM 6-K | Filing Doc | |
| 6-K | FORM 6-K | Filing Doc | |
| 6-K | FORM 6-K | Filing Doc | |
| 6-K | FORM 6-K | Filing Doc | |
| 6-K | FORM 6-K | Filing Doc | |
| 6-K | FORM 6-K | Filing Doc | |
| 6-K | Filing Doc | ||
| SCHEDULE 13G/A | — | Filing Doc | |
| 6-K | FORM 6-K | Filing Doc | |
| 6-K | Filing Doc | ||
| 6-K | FORM 6-K | Filing Doc | |
| 6-K | Filing Doc | ||
| 424B5 | Filing Doc | ||
| 424B5 | Filing Doc | ||
| 6-K | FORM 6-K | Filing Doc | |
| 6-K | FORM 6-K | Filing Doc | |
| 6-K | FORM 6-K | Filing Doc | |
| 6-K | FORM 6-K | Filing Doc | |
| 6-K | Filing Doc | ||
| 6-K | FORM 6-K | Filing Doc | |
| 6-K | FORM 6-K | Filing Doc | |
| 20-F | Filing Doc | ||
| 6-K | FORM 6-K | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.